Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

About the Program

Since 2009, CDC’s Colorectal Cancer Control Program (CRCCP) has provided funding to states and tribal organizations across the United States to increase colorectal (colon) cancer screening rates among men and women aged 50 to 75 years. An increase in screening rates will reduce illness and death caused by colorectal cancer. This will be achieved primarily through non-screening activities aimed at making sure everyone is screened appropriately.

The program has two components: population-based approaches and screening provision.

Population-Based Approaches

Local CRCCP programs use evidence-based strategies recommended by the Task Force on Community Preventive Services to increase colorectal cancer screening, adapting them to their unique needs and situations. Local CRCCP programs work with local comprehensive cancer control programs and other partners to share resources for efficiency. The majority of program funds support these population-based activities.

Screening Provision

Where feasible, local CRCCP programs provide colorectal cancer screening and follow-up care to low-income men and women aged 50 to 64 years who are underinsured or uninsured for screening, when resources are available and there is no other payment option. When possible, screening services are integrated with other publicly funded health programs or clinics that serve underserved populations, such as CDC’s National Breast and Cervical Early Detection Program, CDC’s WISEWOMAN Program, and the Health Resources and Services Administration’s Health Centers.

Since the program’s inception in 2009, CRCCP has provided almost 55,000 colorectal cancer screening exams and diagnosed 165 colorectal cancers and 8,441 cases of precancerous adenomatous polyps. In program year 2014, CRCCP screened 13,425 people for colorectal cancer.

Colorectal Cancer Screening Saves Lives

Of cancers affecting both men and women, colorectal cancer (cancer of the colon and rectum) is the second leading cancer killer in the United States, but it doesn’t have to be. Screening can find precancerous polyps—abnormal growths in the colon or rectum—so they can be removed before turning into cancer. Screening also helps find colorectal cancer at an early stage, when treatment often leads to a cure.